Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mia Wadelius

Showing results (81-90 of 92) with videos related to

Pageof 10
Sort By:
Current Drug Metabolism|February 1, 2014
Incorporation of pharmacogenomics into routine clinical practice: the Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline development processKelly E Caudle, Teri E Klein, James M Hoffman, et al.
Frontiers in Genetics|August 4, 2022
Molecular Genetic Screening in Patients With ACE Inhibitor/Angiotensin Receptor Blocker-Induced Angioedema to Explore the Role of Hereditary Angioedema GenesCarina M Mathey, Carlo Maj, Annika B Scheer, et al.
Clinical Pharmacology and Therapeutics|May 9, 2019
Shared Genetic Risk Factors Across Carbamazepine-Induced Hypersensitivity ReactionsPaola Nicoletti, Sarah Barrett, Laurence McEvoy, et al.
The Pharmacogenomics Journal|February 22, 2020
Genome-wide association study of angioedema induced by angiotensin-converting enzyme inhibitor and angiotensin receptor blocker treatmentEva Rye Rasmussen, Pär Hallberg, Ekaterina V Baranova, et al.
Thrombosis and Haemostasis|December 22, 2011
Pharmacogenetic warfarin dose refinements remain significantly influenced by genetic factors after one week of therapyBenjamin D Horne, Petra A Lenzini, Mia Wadelius, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 5, 2014
Genetic markers of toxicity from capecitabine and other fluorouracil-based regimens: investigation in the QUASAR2 study, systematic review, and meta-analysisDan Rosmarin, Claire Palles, David Church, et al.
Plos One|June 27, 2019
Pharmacogenomics of statin-related myopathy: Meta-analysis of rare variants from whole-exome sequencingJames S Floyd, Katarzyna M Bloch, Jennifer A Brody, et al.
Lancet (London, England)|June 13, 2013
Genetic variants associated with warfarin dose in African-American individuals: a genome-wide association studyMinoli A Perera, Larisa H Cavallari, Nita A Limdi, et al.
The Journal of Allergy and Clinical Immunology|February 1, 2024
Meta-analysis of ACE inhibitor-induced angioedema identifies novel risk locusCarina M Mathey, Carlo Maj, Niclas Eriksson, et al.
Gastroenterology|January 4, 2017
Association of Liver Injury From Specific Drugs, or Groups of Drugs, With Polymorphisms in HLA and Other Genes in a Genome-Wide Association StudyPaola Nicoletti, Guruprasad P Aithal, Einar S Bjornsson, et al.
Pageof 10

Showing results (81-90 of 92) with videos related to

Sort By:
Pageof 10
Current Drug Metabolism|February 1, 2014
Incorporation of pharmacogenomics into routine clinical practice: the Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline development processKelly E Caudle, Teri E Klein, James M Hoffman, et al.
Frontiers in Genetics|August 4, 2022
Molecular Genetic Screening in Patients With ACE Inhibitor/Angiotensin Receptor Blocker-Induced Angioedema to Explore the Role of Hereditary Angioedema GenesCarina M Mathey, Carlo Maj, Annika B Scheer, et al.
Clinical Pharmacology and Therapeutics|May 9, 2019
Shared Genetic Risk Factors Across Carbamazepine-Induced Hypersensitivity ReactionsPaola Nicoletti, Sarah Barrett, Laurence McEvoy, et al.
The Pharmacogenomics Journal|February 22, 2020
Genome-wide association study of angioedema induced by angiotensin-converting enzyme inhibitor and angiotensin receptor blocker treatmentEva Rye Rasmussen, Pär Hallberg, Ekaterina V Baranova, et al.
Thrombosis and Haemostasis|December 22, 2011
Pharmacogenetic warfarin dose refinements remain significantly influenced by genetic factors after one week of therapyBenjamin D Horne, Petra A Lenzini, Mia Wadelius, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 5, 2014
Genetic markers of toxicity from capecitabine and other fluorouracil-based regimens: investigation in the QUASAR2 study, systematic review, and meta-analysisDan Rosmarin, Claire Palles, David Church, et al.
Plos One|June 27, 2019
Pharmacogenomics of statin-related myopathy: Meta-analysis of rare variants from whole-exome sequencingJames S Floyd, Katarzyna M Bloch, Jennifer A Brody, et al.
Lancet (London, England)|June 13, 2013
Genetic variants associated with warfarin dose in African-American individuals: a genome-wide association studyMinoli A Perera, Larisa H Cavallari, Nita A Limdi, et al.
The Journal of Allergy and Clinical Immunology|February 1, 2024
Meta-analysis of ACE inhibitor-induced angioedema identifies novel risk locusCarina M Mathey, Carlo Maj, Niclas Eriksson, et al.
Gastroenterology|January 4, 2017
Association of Liver Injury From Specific Drugs, or Groups of Drugs, With Polymorphisms in HLA and Other Genes in a Genome-Wide Association StudyPaola Nicoletti, Guruprasad P Aithal, Einar S Bjornsson, et al.
Pageof 10